IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27,836,669 | +2.2% | 707,592 | -36.8% | 0.01% | 0.0% |
| Q1 2023 | $27,228,847 | +118.0% | 1,119,147 | +91.8% | 0.01% | +100.0% |
| Q4 2022 | $12,491,836 | -45.9% | 583,458 | -54.7% | 0.00% | -50.0% |
| Q3 2022 | $23,110,000 | +119.4% | 1,288,187 | +17.7% | 0.01% | +100.0% |
| Q2 2022 | $10,531,000 | +3.1% | 1,094,734 | +80.4% | 0.00% | +200.0% |
| Q1 2022 | $10,212,000 | -34.2% | 606,736 | -34.6% | 0.00% | – |
| Q4 2021 | $15,508,000 | +3.1% | 927,534 | +0.1% | 0.00% | -100.0% |
| Q3 2021 | $15,042,000 | +858.1% | 926,206 | +272.4% | 0.00% | – |
| Q2 2021 | $1,570,000 | -60.2% | 248,722 | -61.0% | 0.00% | – |
| Q1 2021 | $3,943,000 | -51.6% | 638,029 | -45.9% | 0.00% | -100.0% |
| Q4 2020 | $8,148,000 | +106.4% | 1,179,174 | +68.5% | 0.00% | – |
| Q3 2020 | $3,947,000 | +137.2% | 699,766 | +114.5% | 0.00% | – |
| Q2 2020 | $1,664,000 | -6.9% | 326,283 | -37.3% | 0.00% | – |
| Q1 2020 | $1,788,000 | -50.6% | 520,073 | +23.3% | 0.00% | -100.0% |
| Q4 2019 | $3,620,000 | – | 421,956 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |